晨光生物(300138.SZ):子公司雲麻生物取得工業大麻加工許可證
格隆匯 7 月 29日丨晨光生物(300138.SZ)公佈,公司全資子公司騰衝晨光雲麻生物科技有限公司(“雲麻生物”),於2020年7月29日取得騰衝市公安局核發的《雲南省工業大麻加工許可證》(批准號:雲南省騰衝縣市區麻加準字202001號),加工種類:工業大麻花葉;有效期限:自2020年7月29日至2022年7月28日。
雲麻生物取得工業大麻加工許可證,對公司推進工業大麻中長期發展規劃有着積極的影響,有助於加快工業大麻業務發展,豐富公司產品種類,增強綜合競爭力,為公司的長期發展提供支持和保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.